TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Chinese Biotech Start-up Antengene Plans Hong Kong IPO, Targeting Gaps In Treatment Of Prevalent Asian Cancers
Play
INVESTING

Acceleron Soars in After-Hours Trading on Positive Trial Results for Hypertension Treatment

PRESS RELEASES

Allakos Announces Pricing Of Public Offering Of Common Stock

PRESS RELEASES

Allakos Previews Preliminary Financial Results For The Three Months Ended September 30, 2020

PRESS RELEASES

Allakos Announces Proposed Public Offering Of Common Stock

PRESS RELEASES

Allakos Announces Publication Of Results From The Phase 2 Study Of Lirentelimab (AK002) In Patients With Eosinophilic Gastritis And/or Eosinophilic Duodenitis (ENIGMA) In The New England Journal Of Medicine

PRESS RELEASES

Allakos Initiates Patient Recruitment For AK002 Registrational Studies

PRESS RELEASES

ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors Of Deadline Today In Securities Class Action First Filed By Firm - ALLK

PRESS RELEASES

ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain To File A Lead Plaintiff Motion In A Securities Class Action Lawsuit Against Allakos Inc.

PRESS RELEASES

ALLK LOSS NOTICE, ROSEN, A TOP FIRM, Reminds Allakos Inc. Investors With Large Losses Of The May 11 Deadline In The Class Action Seeking Recovery Of Investor Losses - ALLK

PRESS RELEASES

ALLAKOS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

PRESS RELEASES

ALLK CLASS ACTION DEADLINE: Bernstein Liebhard Announces That A Securities Class Action Lawsuit Has Been Filed Against Allakos Inc.

PRESS RELEASES

ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Announces That A Securities Class Action Lawsuit Has Been Filed Against Allakos Inc.

PRESS RELEASES

Allakos Announces The Initiation Of Antolimab (AK002) Clinical Studies

PRESS RELEASES

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors Of Class Action And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Allakos Inc. Investors Of Class Action And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors Of Important Deadline In Securities Class Action First Filed By The Firm - ALLK

PRESS RELEASES

ROSEN, NATIONAL INVESTOR COUNSEL, Files First Securities Class Action Lawsuit Against Allakos Inc. - ALLK

PRESS RELEASES

INVESTOR ACTION REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Allakos Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

ALLAKOS ALERT: Bragar Eagel & Squire, P.C. Announces That A Class Action Lawsuit Has Been Filed Against Allakos, Inc. And Encourages Investors To Contact The Firm

PRESS RELEASES

INVESTOR ACTION ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Allakos Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Allakos Inc. - ALLK

PRESS RELEASES

ROSEN, A LEADING LAW FIRM, Continues To Investigate Securities Claims Against Allakos Inc. - ALLK

PRESS RELEASES

ROSEN, A LEADING INVESTOR FIRM, Continues To Investigate Securities Claims Against Allakos Inc. - ALLK

Chinese Biotech Start-up Antengene Plans Hong Kong IPO, Targeting Gaps In Treatment Of Prevalent Asian Cancers
INVESTING

Acceleron Soars in After-Hours Trading on Positive Trial Results for Hypertension Treatment

PRESS RELEASES

ROSEN, A LEADING LAW FIRM, Continues To Investigate Securities Claims Against Allakos Inc. - ALLK